[HTML] cell.comFull View

[HTML][HTML] Robust SARS-CoV-2 infection in nasal turbinates after treatment with systemic neutralizing antibodies

D Zhou, JFW Chan, B Zhou, R Zhou, S Li, S Shan… - Cell host & …, 2021 - cell.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is characterized by a burst
in the upper respiratory portal for high transmissibility. To determine human neutralizing …
被引用次数：105 相关文章

Robust SARS-CoV-2 infection in nasal turbinates after treatment with systemic neutralizing antibodies

D Zhou, JFW Chan, B Zhou, R Zhou, S Li… - Cell host & …, 2021 - pubmed.ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is characterized by a burst
in the upper respiratory portal for high transmissibility. To determine human neutralizing …

[引用][C] Robust SARS-CoV-2 infection in nasal turbinates after treatment with systemic neutralizing antibodies

D Zhou, JFW Chan, B Zhou, R Zhou, S Li, S Shan… - Cell Host & …, 2021 - cir.nii.ac.jp
Robust SARS-CoV-2 infection in nasal turbinates after treatment with systemic neutralizing
antibodies | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
[PDF] seu.edu.cn

[PDF][PDF] Robust SARS-CoV-2 infection in nasal turbinates after treatment with systemic neutralizing antibodies

D Zhou, JFW Chan, B Zhou, DD Ho, KY Yuen, Z Chen - med.seu.edu.cn
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is characterized by a burst
in the upper respiratory portal for high transmissibility. To determine human neutralizing …
[HTML] cell.com

[HTML][HTML] Robust SARS-CoV-2 infection in nasal turbinates after treatment with systemic neutralizing antibodies

D Zhou, JFW Chan, B Zhou, R Zhou, S Li, S Shan… - Cell Host & Microbe, 2021 - cell.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is characterized by a burst
in the upper respiratory portal for high transmissibility. To determine human neutralizing …
[HTML] sciencedirect.com

[HTML][HTML] Robust SARS-CoV-2 infection in nasal turbinates after treatment with systemic neutralizing antibodies

D Zhou, JFW Chan, B Zhou, R Zhou, S Li, S Shan… - Cell Host & Microbe, 2021 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is characterized by a burst
in the upper respiratory portal for high transmissibility. To determine human neutralizing …

Robust SARS-CoV-2 infection in nasal turbinates after treatment with systemic neutralizing antibodies.

D Zhou, JFW Chan, B Zhou, R Zhou, S Li, S Shan, L Liu… - 2021 - cabidigitallibrary.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is characterized by a burst
in the upper respiratory portal for high transmissibility. To determine human neutralizing …

Robust SARS-CoV-2 infection in nasal turbinates after treatment with systemic neutralizing antibodies

D Zhou, JFW Chan, B Zhou, R Zhou, S Li, S Shan… - Cell Host and …, 2021 - hub.hku.hk
© 2021 Elsevier Inc. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
characterized by a burst in the upper respiratory portal for high transmissibility. To determine …
[HTML] nih.gov

[HTML][HTML] Robust SARS-CoV-2 infection in nasal turbinates after treatment with systemic neutralizing antibodies

D Zhou, JFW Chan, B Zhou, R Zhou, S Li… - Cell Host & …, 2021 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is characterized by a burst
in the upper respiratory portal for high transmissibility. To determine human neutralizing …

Robust SARS-CoV-2 infection in nasal turbinates after treatment with systemic neutralizing antibodies.

D Zhou, JF Chan, B Zhou, R Zhou, S Li, S Shan… - Cell Host & …, 2021 - europepmc.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is characterized by a burst
in the upper respiratory portal for high transmissibility. To determine human neutralizing …